313 related articles for article (PubMed ID: 17076680)
1. Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract.
Keller MJ; Herold BC
Am J Reprod Immunol; 2006; 56(5-6):356-63. PubMed ID: 17076680
[TBL] [Abstract][Full Text] [Related]
2. Topical microbicides for the prevention of genital herpes infection.
Keller MJ; Tuyama A; Carlucci MJ; Herold BC
J Antimicrob Chemother; 2005 Apr; 55(4):420-3. PubMed ID: 15743896
[TBL] [Abstract][Full Text] [Related]
3. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
Nikolic DS; Garcia E; Piguet V
Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
[TBL] [Abstract][Full Text] [Related]
4. The role of the local microenvironment in regulating susceptibility and immune responses to sexually transmitted viruses in the female genital tract.
Kaushic C
J Reprod Immunol; 2009 Dec; 83(1-2):168-72. PubMed ID: 19857903
[TBL] [Abstract][Full Text] [Related]
5. Preventing transmission: plant-derived microbicides and mucosal vaccines for reproductive health.
Whaley KJ; Zeitlin L
Vaccine; 2005 Mar; 23(15):1819-22. PubMed ID: 15734048
[TBL] [Abstract][Full Text] [Related]
6. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.
Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377
[TBL] [Abstract][Full Text] [Related]
7. HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment.
Kaushic C; Ferreira VH; Kafka JK; Nazli A
Am J Reprod Immunol; 2010 Jun; 63(6):566-75. PubMed ID: 20384619
[TBL] [Abstract][Full Text] [Related]
8. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.
Kaul R; Pettengell C; Sheth PM; Sunderji S; Biringer A; MacDonald K; Walmsley S; Rebbapragada A
J Reprod Immunol; 2008 Jan; 77(1):32-40. PubMed ID: 17395270
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.
Galen BT; Martin AP; Hazrati E; Garin A; Guzman E; Wilson SS; Porter DD; Lira SA; Keller MJ; Herold BC
J Infect Dis; 2007 May; 195(9):1332-9. PubMed ID: 17397004
[TBL] [Abstract][Full Text] [Related]
10. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation.
Roberts L; Liebenberg L; Barnabas S; Passmore JA
Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):441-9. PubMed ID: 22429786
[TBL] [Abstract][Full Text] [Related]
11. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
Dhawan D; Mayer KH
J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
[TBL] [Abstract][Full Text] [Related]
12. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.
Herold BC; Mesquita PM; Madan RP; Keller MJ
Am J Reprod Immunol; 2011 Mar; 65(3):325-33. PubMed ID: 21143689
[TBL] [Abstract][Full Text] [Related]
13. Dual action microbicides: reappraisal of their roles in contraceptive research.
Chandran P; Kabir SN
Reprod Biomed Online; 2010 Jan; 20(1):103-13. PubMed ID: 20158995
[TBL] [Abstract][Full Text] [Related]
14. Female genital tract immunity: distinct immunological challenges for vaccine development.
Naz RK
J Reprod Immunol; 2012 Jan; 93(1):1-8. PubMed ID: 22154945
[TBL] [Abstract][Full Text] [Related]
15. Topical microbicides for disease prevention: status and challenges.
Harrison PF; Rosenberg Z; Bowcut J
Clin Infect Dis; 2003 May; 36(10):1290-4. PubMed ID: 12746775
[TBL] [Abstract][Full Text] [Related]
16. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites.
Mestecky J
J Reprod Immunol; 2006 Dec; 72(1-2):1-17. PubMed ID: 17095369
[TBL] [Abstract][Full Text] [Related]
18. Microbicides: a new approach to preventing HIV and other sexually transmitted infections.
Stone A
Nat Rev Drug Discov; 2002 Dec; 1(12):977-85. PubMed ID: 12461519
[TBL] [Abstract][Full Text] [Related]
19. Tolerance and protection against infection in the genital tract.
Russell MW; Mestecky J
Immunol Invest; 2010; 39(4-5):500-25. PubMed ID: 20450289
[TBL] [Abstract][Full Text] [Related]
20. Engineering immunity in the mucosal niche against sexually transmitted infections.
Ramanathan R; Woodrow K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):107-22. PubMed ID: 26153141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
